Trial Profile

A Non-interventional Study to Assess Effectiveness and Safety of Trifluridin/Tipiracil in Patients With Metastatic Colorectal Cancer

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tipiracil/trifluridine (Primary)
Indications Colorectal cancer
Focus Therapeutic Use
Acronyms TACTIC
Sponsors Servier

Most Recent Events

02 Jul 2022 Results (n=307; From June 2018 to August 2021) assessing the efficacy and safety data from patients with pre-treated metastatic colorectal cancer receiving trifluridine/tipiracil, presented at the 24th World Congress on Gastrointestinal Cancer.
19 Nov 2021 Status changed from active, no longer recruiting to completed.
01 Apr 2021 Planned End Date changed from 1 Jun 2021 to 1 Aug 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com